Accordingly, in this study, we investigated the clinical outcomes of patients with advanced cSCC treated with anti-PD-1 ICI outside clinical trials at a Canadian Comprehensive Cancer Centre. The gene discussed is PDCD1; the disease is skin squamous cell carcinoma.